Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionExodusPoint Capital Management, LP
Latest Disclosed Ownership244,838 shares
Latest Disclosed Value $ 3,540,357
ExodusPoint Capital Management, LP ownership in FOLD / Amicus Therapeutics, Inc.

On May 14, 2026 - ExodusPoint Capital Management, LP filed a 13F-HR form disclosing ownership of 244,838 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $3,540,357 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of Amicus Therapeutics, Inc.. The current value of the position is $3,547,703 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AMICUS THERAPEUTICS COM 03152W109 244,838 244,838 3,540 0.0286
2026-02-17 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -123,374 -100.00 0 -100.00
2025-11-14 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 123,374 123,374 972 0.0099
2025-08-13 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -332,207 -100.00 0 -100.00
2025-05-14 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 332,207 53,138 19.04 3 0.00 0.0268
2025-02-12 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 279,069 -537,938 -65.84 3 -75.00 0.0180
2024-11-12 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 817,007 35,490 4.54 9 14.29 0.0531
2024-08-13 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 781,517 138,132 21.47 8 0.00 0.0529
2024-05-14 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 643,385 271,005 72.78 8 40.00 0.0578
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 372,380 -569,053 -60.45 5 -54.55 0.0347
2023-11-13 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 941,433 317,580 50.91 11 57.14 0.1094
2023-08-11 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 623,853 468,018 300.33 8 600.00 0.0637
2023-05-11 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 155,835 40,044 34.58 2 0.00 0.0143
2023-02-13 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 115,791 -177,189 -60.48 1 -99.97 0.0205
2022-11-10 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 292,980 163,746 126.71 3,059 120.39 0.0400
2022-08-22 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 129,234 129,234 1,388 0.0170
2022-05-12 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -20,758 -100.00 0 -100.00
2022-02-11 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 20,758 -177,013 -89.50 240 -87.29 0.0025
2021-11-15 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 197,771 109,376 123.74 1,889 121.71 0.0255
2021-08-16 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 88,395 -2,942 -3.22 852 -5.54 0.0094
2021-05-17 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 91,337 10,147 12.50 902 -51.89 0.0132
2021-02-16 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 81,190 -25,326 -23.78 1,875 24.67 0.0183
2020-11-16 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 106,516 106,516 1,504 0.0300
2020-05-15 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -46,457 -100.00 0 -100.00
2020-02-14 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 46,457 23,757 104.66 452 148.35 0.0085
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 22,700 22,700 182 0.0064
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.